‐1‐Bishop PB, Bray RC: Abnormal joint mechanics and the proteoglycan composition of normal and healing rabbit medial collateral ligament. JMPT 1994; 16(5):300‐5

‐2‐Bockman RS et al: Steroid-induced osteoporosis. Ortho Clin of N Amer 21(1):97

‐3‐Boxberger JI, Sen S, Yerramalli CS, EllioƩ DM: Nucleus pulposus glycosaminoglycan content is correlated with axial mechanics in rat lumbar motion segments. Journal Of Othopedic Research 2006; 24 (9):1906‐1915

‐4‐Bucci L, Poor G: Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow‐acting drug for osteoarthritis in the treatment of knee osteoarthritis. Osteoarthritis and Cartilage 1998;6(A):31‐6

‐5‐Bucci LR: Reversal of osteoarthritis by nutritional intervention. ACA J Chiro 11/90

‐6‐DeVries: Arthritis and Rheumatism 1985; 28:922‐9;

‐7‐Fassender HM et al: Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis and Cartilage 1994; 2(1):61‐69.

‐8‐Fessler: [Chronic steroid use leads to epidural lipomatosis.] Spine 1992; 17(2)

‐9‐Fries: Prednisone greatly increases fracture risk. J of Musculoskeletal Med (6/92):16

‐10‐Guehring T, Omlor G, Lorenz H et al: Disc Distraction Shows Evidence of Regenerative Potential in Degenerated Intervertebral Discs as Evaluated by Protein Expression, Magnetic Resonance Imaging, and Messenger Ribonucleic Acid Expression Analysis. Spine 2006;31(15):1658‐1665

‐11‐Jackson AR, Huang CY, Gu WY: Effect of endplate calcification and mechanical deformation on the distribution of glucose in intervertebral disc: a 3D finite element study. Computer Methods In Biomechanics And Biomedical Engineering 2011;14(2 sp ISS):195‐204

‐12‐Laan: Arthritis and sciatica drug weakens vertebrae. BackleƩer 1994;9(2):22

‐13‐Mazurov VI, Belyaeva IB: Structum in combined treatment of low back pain syndrome. TERAPEVTICHESKII ARKHIV 2004; 76 (8):68‐71

‐14‐Melrose, Ghosh, Taylor, Osti, Vernon‐Roberts: A longitudinal study of the matrix changes induced in the intervertebral disc by surgical damage to the anulus fibrosus. Journal of Orthopedic Research, vol. 10

‐15‐Mitchell: [Steroid use causes osteo‐degenerative arthritic hips]. Radiology 1987; 62(3):709

‐16‐Newman: Lancet 1985; pgs. 11‐14

‐17‐Olivero U et al: Effects of treatment with matrix on elderly people with chronic articular degeneration.

‐18‐Olsen: Acta Orthop Scand 1989; 60(1):23‐25

‐19‐Palmoski: Arthritis and Rheumatism 1985; 28:548;

‐20‐Pearce: J of Orthopedic Research 5(2)

‐21‐Pepitone VR: Chondroprotection with chondroitin sulfate. Drugs in experimental and clinical research 1991;17(1):3‐7

‐22‐Pujalte JM et al: Double‐blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis.” Curr Med Res Opin 1980;7:110‐14

‐23‐Ratliffe: Increased release of matrix components from articular cartilage in experimental canine osteoarthritis. J of Orthopedic Research, vol. 10

‐24‐Ray: Cyclic antidepressants may increase hip fracture risk. J of Manipulative Medicine (12/91):46

‐25‐Ronca F: Anti‐inflammatory activity of chondroitin sulfate. Osteoarthritis and Cartilage 1998;68(A):14‐21

‐26‐RoveƩa G: Galactosaminoglycan sulfate (matrix) in therapy of tibiofibular osteoarthrosis of the knee. Drugs in Experimental and Clin Research 1991; 18(1):53‐57.

‐27‐Shirazi‐Adl A, Taheri M, Urban JPG: Analysis of cell viability in intervertebral disc: Effect of endplate permeability on cell population. Journal Of Biomechanics 43 (7). MAY 7 2010. p.1330‐1336

‐28‐Shostak NA et al: Low back pain in spinal osteochondrosis: experience of treatment with chondroprotective drug. Terapevtichjeskii Arkhiv 2002; 74(8):67‐69

‐29‐Soldani G, Romangnoli J: Experiment and clinical pharmacology of glycosaminoglycan (GAGS). Drugs in Experimental and Clinical Research 1991; 18(1):81‐85.

‐30‐Uebelhart D: Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis and Cartilage.1998;6(A):39‐46

‐31‐VanDerKraan et al: High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability. J of Ortho Research 1990; 8(4):565‐71

‐32‐Vaz: Double‐blind clinical evaluation of relative efficacy of glucosamine sulphate in the management of osteoarthritis of knee in out‐patients. Curr Med Res Opin ‘82;8:145‐9.

‐33‐Wellburn M: Shotgun approach may quell arthritis, rheumatism, and back pain! J of Arthritis Research 1994; Sept:15‐22.

‐34‐WhiƩaker: Arthritis drugs actually cause cartilage destruction! Health & Healing 3(6):1‐4

‐35‐Yoo: Suppression of proteoglycan synthesis in chondrocyte cultures derived from canine intervertebral disc. Spine 17(2):221‐224

‐36‐Cole TC, Ghosh P, Taylor TKF: Arteparon modifies proteoglycan turnover in the intervertebral disc. British J of Bone and Joint Surgery 1988; 70B(1):166

‐37‐Aitman: Arthritis and Rheumatism 1991; 31(1)

‐38‐Reicht A, Forster KK, FIscher M et al: Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. ArzneimiƩle‐Foschung 1994; 44(1):75‐80

‐39‐(Note: The quote reference 39 is from Wang.—See reference #49 below.) Hee HT, Zhang JT, Wong HK: Effects of Cyclic Dynamic Tensile Strain on Previously Compressed Inner Annulus Fibrosus Pulposus Cells of Human Interverte‐

bral Disc‐An In Vitro Study. JOURNAL OF ORTHOPAEDIC RESEARCH 2010;28(4):503‐509 ‐40‐John I. Boxberger. Nucleus pulposus glycosaminoglycan content is correlated with axial mechanics in rat lumbar motion segments. J OF ORTHOPAEDIC RESEARCH, Issue 9, 2006

‐41‐ (aging information) Cho (see #51 below) or (neurite formation information) Bao (see #52 below)

‐42‐Zhao, CQ; Wang, LM; Jiang, LS; Dai, LY. The cell biology of intervertebral disc aging and degeneration. AGEING RESEARCH REVIEWS 6 (3). OCT 2007. p.247‐261

‐43‐Sasaki N, Henriksson H, Runesson E, et al: Physical Exercise Affects Cell Proliferation in Lumbar Intervertebral Disc Regions in Rats. Spine 2012; 37(17): 1440–1447

‐44‐Guehring, Thorsten MD*; Omlor, Georg W. MD*; Lorenz, Helga DVM*; Engelleiter, Karl MD*; Richter, Wiltrud PhD*; Carstens, Claus MD*; Kroeber, Markus MD: Disc Distraction Shows Evidence of Regenerative Potential in Degenerated Intervertebral Discs as Evaluated by Protein Expression, Magnetic Resonance Imaging, and Messenger Ribonucleic Acid Expression Analysis. Spine: Volume 31(15) 1 July 2006 pp 1658‐1665

‐45‐Mavrogonatou, Eleni PhD; Kletsas, Dimitris PhD The Effect of Glucosamine Sulfate on the Proliferative Potential and Glycosaminoglycan Synthesis of Nucleus Pulposus Intervertebral Disc Cells. Spine: 15 February 2013 ‐ Volume 38 ‐ Issue 4 ‐ p 308–314

‐46‐Hee, HT; Zhang, JT; Wong, HK. Effects of Cyclic Dynamic Tensile Strain on Previously Compressed Inner Annulus Fibrosus and Nucleus Pulposus Cells of Human Intervertebral Disc‐An In Vitro Study. JOURNAL OF ORTHOPAEDIC RESEARCH 28 (4). APR 2010. p.503‐9

‐47‐Hee, HT; Chuah, YJ; Tan, BHM; Setiobudi, T; Wong, HK. Vascularization and Morphological Changes of the Endplate AŌer Axial Compression and Distraction of the Intervertebral Disc. SPINE 36 (7). APR 1 2011. p.505‐511

‐48‐Daniells S (Nutra USA): Anti‐Inflammatory Properties of Perna Canaliculus: Studies support green‐lipped mussel’s anti-inflammatory properties. hƩp://www.nutraingredients‐usa.com/news/ng.asp?id=79246‐lyprinol‐green‐lipped‐mussel‐omega (sourced on 7/15/12)

‐49‐Wang SZ, Rui YF, Tan Q, Wang C. Enhancing intervertebral disc repair and regeneration through biology: platelet‐rich plasma as

an alternative strategy. Arthritis Res Ther. 2013 Oct 28;15(5):220. [Epub ahead of print]

‐50‐Wim J van BliƩerswijk, Jos CM van de Nes, Paul IJM Wuisman: Glucosamine and chondroitin sulfate supplementation to treat

symptomatic disc degeneration: biochemical rationale and case report. BMC Complementary and Alternative Medicine 2003;3:2

‐51‐Cho, H; Park, SH; Lee, S; Kang, M; Hasty, KA; Kim, SJ. Snapshot of degenerative aging of porcine intervertebral disc: a model to unravel the molecular mechanisms. EXPERIMENTAL AND MOLECULAR MEDICINE 43 (6). JUN 30 2011. p.334‐340

‐52‐Bao X, Nishimura S, Mikami T: Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains from Embryonic Pig Brain, Which Contain a Higher Proportion of L‐Iduronic Acid than Those from Adult Pig Brain, Exhibit Neurogenic and Growth Factor Binding Activities.

Journal of Biological Chemistry www.jbc.org First Published on December 29, 2003, March 12, 2004 The Journal of Biological Chemistry, 279, 9765‐9776.

‐53‐Gu W, Zhu Q , Gao X, Brown M. Simulation of the Progression of Intervertebral Disc Degeneration Due to Decreased Nutritional Supply. Spine 2014;39(24):E1411–E1417

‐54‐Shirazi‐Adl A, Taheria M, Urban JPG: Analysis of cell viability in intervertebral disc: Effects of endplate permeability on cell population. J of Biomechanics 2010; 43(7):1330‐1336

‐55‐Zao CQ, Wang LM, Jiang LS, Dai LY. The cell biology of intervertebral disc aging and degeneration. AGEING RESEARCH REVIEWS 2007;6(3):247‐261

‐56‐Bishnoi M, Jain A, Hurkat P, Jain SK. Chondroitin sulfate: a focus on osteoarthritis. Glycoconj J. 2016 Oct;33(5):693‐705. doi: 10.1007/s10719‐016‐9665‐3. Epub 2016 May 19.

‐57‐Schleich C, Müller‐Lutz A, Eichner M, SchmiƩ B, Matuschke F, IƩersohl B, Zilkens C, WiƩsack H, Antoch G, Miese F . Glycosaminoglycan Chemical Exchange Saturation Transfer of Lumbar Intervertebral Discs in Healthy Volunteers. Spine 2016;41(2) ‐ p 146–152 doi: 10.1097/BRS.0000000000001144

‐58‐Deng M, Yuan J, Chen WT, Chan Q, Griffith JF, Wang YX. Evaluation of Glycosaminoglycan in the Lumbar Disc Using Chemical Exchange Saturation Transfer MR at 3.0 Tesla: Reproducibility and Correlation with Disc Degeneration.Biomed Environ Sci.

2016;(1) ‐ p 47‐55. doi: 10.3967/bes2016.005.

‐59‐Pearce RH, Grimmer BJ, Adams ME: Degeneration and chemical composition of the human intervertebral disc. J Ortho Research 1987;5(2):198‐205.

‐60‐Cho H, Park SH, Lee S, Kang M, Hasty KA, Kim SJ. Snapshot of degenerative aging of porcine intervertebral disc: a model to unravel the molecular mechanisms. EXPERIMENTAL AND MOLECULAR MEDICINE 2011;43(6):334‐340

‐61‐Jacobs L, Vo N, Coelho JP, Dong Q, Bechara B, Woods B. Glucosamine Supplementation Demonstrates a Negative Effect on Intervertebral Disc Matrix in an Animal Model of Disc Degeneration. Spine 2013;38(12):984–990

‐62‐Bascoul C, Garaiova I, Plummer, Harwood, Caterson, Hughes. Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin‐1α in Bovine Cartilage Explants. Cartilage 2016;(1):70‐81. doi: 10.1177/1947603515603762

‐63‐Treschow AP, Hodges LD, Wright, Wynne PM, Kalafatis N, Macrides TA. “Novel anti‐inflammatory 1‐3 PUFAs from the New

Zealand green‐lipped mussel, Perna canaliculus” Comparative Biochemistry and Physiology 147(B): 645‐656

‐64‐McPhee S, Hodges LD, Wright, Wynne P, Kalafatis N, Harney DW, Macrides TA. “Anti‐cyclooxygenase effects of lipid extracts from the New Zealand green‐lipped mussel, Perna canaliculus” Comparative Biochemistry and Physiology 146(B):346‐356

‐65‐Tat SK, Pelletier JP, Mineau F, Duval N, Martel‐Pelletier J. Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage/chondrocytes: relevance of purity and production process. J Rheumatol. 2010;37(3):656‐64. doi:

10.3899/jrheum.090696. Epub 2010 Jan 28.

‐66‐Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996;23(8):1385‐91.

‐67‐Volpi N. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment. Curr Drug Targets Immune Endocr Metabol Disord. 2004;4(2):119‐27.

‐68‐Alekseeva LI, Benevolenskaia LI, Nasonov EL, Chichasova NV, Kariakin AN. [Structum (chondroitin sulfate)‐‐a new agent for the treatment of osteoarthrosis]. Ter Arkh. 1999;71(5):51‐3

‐69‐Maheu E, Rannou F, Reginster JY. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real‐life seƫng trials and surveys. Semin Arthritis Rheum. 2015 Dec 2. pii: S0049‐0172(15)00286‐3. doi: 10.1016/j.semarthrit.2015.11.008. [Epub ahead of print]

‐70‐Man AJ, Leach JK, Bannerman P. Redirection of neurite outgrowth by coupling chondroitin sulfate proteoglycans to polymer membranes. Ann Biomed Eng. 2014;42(6):1271‐81. doi: 10.1007/s10439‐014‐0991‐y. Epub 2014 Feb 26.

‐71‐Bao X, Shuji N, Tadahisa M. Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains from Embryonic Pig Brain, Which Contain a Higher Proportion of L‐Iduronic Acid than Those from Adult Pig Brain, Exhibit Neurogenic and Growth Factor Binding Activities.

Journal of Biological Chemistry www.jbc.org First Published on December 29, 2003, March 12, 2004 The Journal of Biological Chemistry, 279, pgs. 9765‐9776.

‐72‐Nemoto W, Yamada K, Ogata Y, Nakagawasai O, Onodera K, Sakurai H, Tan‐No K. Chondroitin sulfate aƩenuates formalininduced persistent tactile allodynia. J Pharmacol Sci. 2016 Aug 5. pii: S1347‐8613(16)30091‐3. doi: 10.1016 / j.jphs.2016.07.009.

‐73‐Mazuro VI, Velyacva IB. Structum in combined treatment of low back pain syndrome. Terapevticheskii arkhib 2004;76(8):68‐71

‐74‐Shostak NA et al: Low back pain in spinal osteochondrosis: experience of treatment with chondroprotective drug (article Russian). Terapevtichjeskii Arkhiv 2002;74(8):67‐69

‐75‐Seleznova S, Zabara A, Mamuladze D. THE CURRENT PROBLEMS OF NONSPECIFIC BACK PAIN. Georgian Med News. 2016;(250):61‐66

‐76‐Singh JA, Noorbaloochi S, MacDonald R, Maxwell. Chondroitin For Osteoarthritis. Cochrane Database Syst Rev. 2015 Jan 28;1:CD005614. doi: 10.1002/14651858.CD005614.pub2.

‐77‐Hochberg MC, Clegg DO: Potential effects of chondroitin sulfate on joint swelling: a GAIT report. Arthritis Rheum. 2009;60(2):524‐33

‐78‐Monfort J, Martel‐Pelletier J, Pelletier JP. Chondroitin sulfate for symptomatic osteoarthritis: critical appraisal of meta-analyses. Curr Med Res Opin. 2008;24(5):303‐8. doi: 10.1185/030079908X297231 Epub 2008 Apr 15.

‐79‐Tyler S, Ryan D, Yuntao Z. et al: Corneal Sulfated Glycosaminoglycans and Their Effects on Trigeminal Nerve Growth Cone Behavior In Vitro: Roles for ECM in Cornea Innervation. Investigative Ophthalmology & Visual Science www.iovs.org Published online before print November 6, 2012, Ophthalmol. Vis. Sci. 2012;53(13):8118‐8137

‐80‐Kantor ED, Zhang X, Wu K, et al. Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses’ Health Study and Health Professionals follow‐up study. Int J Cancer 2016;139(9):1949‐57. doi: 10.1002/ijc.30250. Epub 2016 Jul 18.

‐81‐Kantor ED, Lampe JW, Peters U, et al. Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes Control 2013;24(6):1137‐46. doi: 10.1007/s10552‐013‐0192‐2. Epub 2013 Mar 26.

‐82‐Kantor ED, Lampe JW, Navarro SL, et al. Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation. J Altern Complement Med. 2014; 20(6):479‐85. doi: 10.1089/acm.2013.0323. Epub 2014 Apr 16.

‐83‐Brasky TM, Lampe JW, Slatore CG, White E. Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control 2011;22(9):1333‐42. doi: 10.1007/s10552‐011‐9806‐8. Epub 2011 Jun 25.

‐84‐Satia JA, LiƩman A, Slatore CG, Galanko JA, White E. Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1419‐28. doi: 10.1158/1055‐9965.EPI‐09‐0038.

‐85‐Porter K1, Hoey L2, Hughes CF3, Ward M4, McNulty H5. Causes, Consequences and Public Health Implications of Low B‐Vitamin Status in Aging. Nutrients. 2016 Nov 16;8(11). pii: E725.

‐86‐Bailey RL, van Wijngaarden JP. The Role of B‐Vitamins in Bone Health and Disease in Older Adults. Curr Osteoporos. Rep. 2015 May 28. [Epub ahead of print]

‐87‐Takeoka Y, Paladugu P, Kang JD, Mizuno S. Augmented Chondroitin Sulfate Proteoglycan Has Therapeutic Potential for Intervertebral Disc Degeneration by Stimulating Anabolic Turnover in Bovine Nucleus Pulposus Cells under Changes in Hydrostatic Pressure. Int J Mol Sci. 2021 Jun 2;22(11):6015.

‐88‐Veronese N, Demurtas J, Smith L, Reginster JY, Bruyère O, Beaudart C, Honvo G, Maggi S; on behalf of the European Geriatric

Medicine Society Special Interest Groups in Systematic Reviews and Meta‐Analyses and Arthritis. Glucosamine sulfate: an umbrella review of health outcomes. Ther Adv Musculoskelet Dis. 2020 Dec 26;12:1759720X20975927.

‐89‐Rabade A, Viswanatha GL, Nandakumar K, Kishore A. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta‐analysis. Inflammopharmacology. 2024 Apr 6. doi: 10.1007/s10787‐024‐01460‐9. Epub ahead of print. PMID: 38581640.

‐90‐Li ZH, Gao X, Chung VC, et al. Associations of regular glucosamine use with all‐cause and cause‐specific mortality: a large prospective cohort study. Ann Rheum Dis. 2020 Jun;79(6):829‐836. doi: 10.1136/annrheumdis‐2020‐217176. Epub 2020 Apr 6.

‐91‐Melgar‐Lesmes P, Garcia‐Polite F, Del‐Rey‐Puech P, Rosas E, Dreyfuss JL, Montell E, Vergés J, Edelman ER, Balcells M. Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity. Atherosclerosis. 2016 Feb;245:82‐7.

‐92‐Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, Heianza Y, Qi L. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019 May 14;365:l1628. doi: 10.1136/bmj.l1628.

‐93‐Zhou C, Zhang Y, Yang S, Ye Z, Wu Q, Liu M, He P, Zhang Y, Qin X. Habitual glucosamine use, APOE genotypes, and risk of incident cause‐specific dementia in the older population. Alzheimers Res Ther. 2023 Sep 9;15(1):152.

‐94‐Zheng J, Ni C, Zhang Y, Huang J, Hukportie DN, Liang B, Tang S. Association of regular glucosamine use with incident dementia: evidence from a longitudinal cohort and Mendelian randomization study. BMC Med. 2023 Mar 29;21(1):114.

References for Discat Plus Enhanced VIDEO:

– Bishoni—2016—#56

– Radek—2015—Radek M, Pacholczyk-Sienicka B, Jankowski S, Albrecht Ł, Grodzka M, Depta A, Radek A. Assessing the correlation between the degree of disc degeneration on the Pfirrmann scale and the metabolites identified in HR-MAS NMR spectroscopy. Magn Reson Imaging. 2015 Dec 17. pii: S0730-725X(15)00300-8. doi: 10.1016/j.mri.2015.12.005. [Epub ahead of print]

– Yang– 2016—Yang SR1, Peng S1, Ko CY1, Chu IM2.The effects of different molecular weight chondroitin-4-sulfates in chondrocyte pellet culture.Cytotechnology. 2016 May;68(3):371-9. doi: 10.1007/s10616-014-9788-y. Epub 2014 Oct 5.

– Singh—2015—#76

– Tat– 2010—#65

– Ubelhardt—2008— #37

– Volpi—2004—#67

– Morreale—1996—#66

– Xingfeng—2003—#52

– Koike—2015—Koike T1, Mikami T, Shida M, Habuchi O, Kitagawa H.Chondroitin sulfate-E mediates estrogen-induced osteoanabolism.Sci Rep. 2015 Mar 11;5:8994. doi: 10.1038/srep08994.

– Purmessor—2015—Purmessur D1, Cornejo MC1, Cho SK1, Roughley PJ2, Linhardt RJ3, Hecht AC1, Iatridis JC4.Intact glycosaminoglycans from intervertebral disc-derived notochordal cell-conditioned media inhibit neurite growth while maintaining neuronal cell viability. Spine J. 2015 May 1;15(5):1060-9. doi: 10.1016/j.spinee.2015.02.003. Epub 2015 Feb 7.

– Kantor —2013—Kantor ED, Zhang X, Wu K, Signorello LB, Chan AT, Fuchs CS, Giovannucci EL. Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses’ Health Study and Health Professionals Follow-up Study. Int J Cancer. 2016 Nov 1;139(9):1949-57. doi: 10.1002/ijc.30250. Epub 2016 Jul 18.

– Satia—2009—#84

– Brasky—2011—#83

– Kantor—2014—#82

– Navarro—2015—Navarro SL1, White E1, Kantor ED2, Zhang Y1, Rho J1, Song X1, Milne GL3, Lampe PD1, Lampe JW1.Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. PLoS One. 2015 Feb 26;10(2):e0117534. doi: 10.1371/journal.pone.0117534. eCollection 2015.

– Bell—2012—Bell GA1, Kantor ED, Lampe JW, Shen DD, White E.Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012 Aug;27(8):593-603. doi: 10.1007/s10654-012-9714-6. Epub 2012 Jul 25.